prednisone has been researched along with Carcinogenesis in 4 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, J | 2 |
| He, Z | 1 |
| Zhu, Y | 1 |
| Jiang, C | 1 |
| Deng, Y | 1 |
| Wei, B | 1 |
| Chen, L | 1 |
| Yang, J | 1 |
| Zheng, M | 1 |
| Kong, X | 1 |
| Huang, T | 1 |
| Cai, YD | 1 |
| Peng, W | 1 |
| Feng, J | 1 |
| Ren, Y | 1 |
| Gu, Y | 1 |
| Wang, W | 1 |
| Wang, J | 1 |
| Li, X | 1 |
| Wang, Y | 1 |
| Gao, H | 1 |
| Dong, X | 1 |
| Tian, Y | 1 |
4 other studies available for prednisone and Carcinogenesis
| Article | Year |
|---|---|
ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinogenesis; Cell Line, Tumor; | 2021 |
The Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung Cancer.
Topics: Animals; Antineoplastic Agents; Arsenicals; Berberine; Carcinogenesis; Carcinoma, Non-Small-Cell Lun | 2015 |
LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomar | 2017 |
Expression of the significance of silent information regulator type-1 in Angioimmunoblastic T-cell lymphoma is greater association with tumorigenesis and has strong implications for adverse prognosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinogenesis; Cyclophosphamide; Doxorubicin; | 2016 |